Hypertension Clinical Trial
Official title:
Health Status Factors Predicting Responses to Long-Term Training: Effects of 16-Week High-Intensity Interval Training on Pre-Hypertensive Subjects
Verified date | October 2018 |
Source | Universidad Santo Tomas |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Despite exercise training decrease blood pressure in 'average' terms, there is a wide interindividual variability after exercise training, being yet unknown what mode of exercise (e.g. endurance, strength, concurrent, or high intensity interval training) produce more/less non-responder (NR) prevalence (i.e., percentage of subjects who experienced a non-change/worsened response after training in some outcome).
Status | Completed |
Enrollment | 142 |
Est. completion date | February 2017 |
Est. primary completion date | December 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 20 Years to 40 Years |
Eligibility |
Inclusion Criteria: - Written informed consent; - Interested in improving health and fitness; - Systolic blood pressure > 120 mmHg and < 140 mmHg, and/or DBP = 80 and < 90 mmHg according with standard classification; - No drug therapy during the previous 3 months; - Body mass index (BMI) 25 and 35 kg/m2); (c) physically inactive (according to the International Physical Activity Questionnaire previously validated in Chilean population) - Normal /mild altered lipid profile (total cholesterol [TC] ~200 and =250 mg/dL, low-density lipids [LDL-C] ~140 mg/dL and =200 mg/dL, high-density lipids [HDL-C] =20 and ~40 mg/dL, triglycerides ~150 and =250 mg/dL) according with standard classification. Exclusion Criteria: - Cardiovascular contraindications to exercise histories of stroke; - Asthma and chronic obstructive pulmonary disease; - Musculoskeletal disorder such as low back pain; - Smokers in the last 3 months were not included in the study. |
Country | Name | City | State |
---|---|---|---|
Chile | Cristian Alvarez | Osorno |
Lead Sponsor | Collaborator |
---|---|
Universidad Santo Tomas | Healthcare Center Tomas Rojas, Universidad del Rosario, Universidad Pública de Navarra, University of Los Ríos |
Chile,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from Baseline in systolic blood pressure and diastolic blood pressure | After this, we calculated the delta changes in both variables and classified to all subjects in responders (R) and non-responders (NR) to decrease systolic or diastolic blood pressure. | Baseline and 16 weeks immediately after the interventions ends | |
Secondary | Change from Baseline in body mass | Baseline and 16 weeks immediately after the interventions ends | ||
Secondary | Change from Baseline in body mass index | BMI will be calculated as the body weight in kilograms divided by the square of the height in meters. | Baseline and 16 weeks immediately after the interventions ends | |
Secondary | Change from Baseline in waist circumference | Baseline and 16 weeks immediately after the interventions ends | ||
Secondary | Change from Baseline in fat mass | Baseline and 16 weeks immediately after the interventions ends | ||
Secondary | Change from Baseline in heart rate at rest | Baseline and 16 weeks immediately after the interventions ends | Baseline and 16 weeks immediately after the interventions ends | |
Secondary | Change from Baseline in fasting glucose | Baseline and 16 weeks immediately after the interventions ends | ||
Secondary | Change from Baseline in lipids | Lipid profile (low-density cholesterol, total cholesterol, high-density cholesterol and triglycerides) | Baseline and 16 weeks immediately after the interventions ends | |
Secondary | Change from Baseline in one maximum repetition strength test of leg-extension exercise | Baseline and 16 weeks immediately after the interventions ends |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |